Professor Daniel Tak Mao CHAN, MBBS, MD, FRCP(UK), FHKCP, FHKAM, FASN

Professor Daniel Tak Mao CHAN, MBBS, MD, FRCP(UK), FHKCP, FHKAM, FASN

University of Hong Kong, Queen Mary Hospital,
Hong Kong, China

Daniel Tak Mao Chan is currently Chair Professor, Yu Chiu Kwong Professor of Medicine, and Chief of Nephrology at the Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong.

He graduated from the University of Hong Kong in 1985 and received training in nephrology and internal medicine in Hong Kong and at Guy’s Hospital in London, United Kingdom. Professor Chan is a Fellow of the Hong Kong College of Physicians, Hong Kong Academy of Medicine, and the Royal College of Physicians in the United Kingdom. He was appointed Professor of Medicine in 1999 and Chair Professor in 2005. He has served as Chief of Clinical Service at the Department of Medicine and Associate Dean of the Li Ka Shing Faculty of Medicine, and is now an elected Member of the Senate at the University of Hong Kong.

Professor Chan has previously served as President of the Asian Pacific Society of Nephrology, President of the Hong Kong Society of Transplantation, Chairman of the Nephrology Board and Programme Director of the Advanced Internal Medicine Board of the Hong Kong College of Physicians. He is currently Chairman of the Central Coordinating Committee for Internal Medicine of the Hong Kong Hospital Authority, vice-President of the Hong Kong Kidney Foundation, Medical Subgroup Member of the Steering Committee on Strategic Review on Healthcare Manpower Planning and Professional Development of the Hong Kong Government, Council Member of the Hong Kong College of Physicians, and Honorary Treasurer of the Asian Society of Transplantation. He is recipient of the Kenzo Oshima Award from the Asian Pacific Society of Nephrology.

Professor Chan’s research interests include the treatment and pathogenesis of lupus nephritis and viral hepatitis in kidney transplant recipients. He is recognised for pioneering work on the use of mycophenolate mofetil in the treatment of lupus nephritis. His research impact is ranked in the top 1% internationally by Essential Science Indicators.

Disclosures

None

Secretariat
Lupus Academy Foundation
Maasdijk 409
4264 AS Veen
The Netherlands
Tel: +31 (0) 416 693 925
Email: secretariat@lupus-academy.org